You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

New Frontiers in Sustained Delivery: New Data and Surgical Advances for Age-Related Macular Degeneration and Diabetic Eye Disease

  • Authors: Carl D. Regillo, MD; Dante J. Pieramici, MD; Charles C. Wykoff, MD, PhD
  • CME Released: 10/28/2021
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 10/28/2022, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for ophthalmologists, diabetologists, and endocrinologists.

The goal of this activity is to discuss the latest clinical data concerning emerging sustained-delivery treatments for age-related macular degeneration (AMD) and diabetic eye disease and to offer surgical and clinical insights for using this treatment and approach in daily practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Options for durable treatments for AMD and diabetic eye disease
    • Safety and efficacy data for sustained-release retina treatments
  • Have greater competence related to
    • Application of best practices for port delivery
  • Demonstrate greater confidence in their ability to
    • Manage AMD and diabetic eye disease over the long term


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Carl D. Regillo, MD

    Professor of Ophthalmology
    Thomas Jefferson University
    Director, Retina Service
    Wills Eye Hospital
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Carl D. Regillo, MD, has the following relevant financial relationships:
    Advisor or consultant for: Adverum Biotechnologies; Alderya Therapeutics; Allergan, Inc.; Annexon Biosciences; Aviceda Therapeutics; Chengdu Kanghong Pharmaceutical Group Co., Ltd.; EyePoint Pharmaceuticals, Inc.; Genentech; Graybug Vision; Iveric Bio; Kodiac Sciences; Lineage Cell Therapeutics; Merck; NGM Biopharmaceuticals, Inc.; Notal Vision; Novartis; Ocugen; Opthea Ltd; Stealth BioTherapeutics; Takeda; Théa Pharmaceuticals; Zeiss Pharma Ltd.
    Grants for clinical research from: Adverum Biotechnologies; Allergan, Inc; Annexon Biosciences; Astellis Pharma, Inc.; Chengdu Kanghong Pharmaceutical Group Co., Ltd; Eyepoint Pharmaceuticals, Inc.; Genentech; Graybug Vision; Iveric Bio; Kodiac Sciences; Lineage Cell Therapeutics; NGM Biopharmaceuticals, Inc.; Notal Vision; Novartis; Opthea Ltd; Regeneron; REGENXBIO, Inc.

  • Dante J. Pieramici, MD

    Vitreoretinal Surgeon
    California Retinal Consultants
    Director
    California Retina Research Foundation
    Santa Barbara, California

    Disclosures

    Disclosure: Dante J. Pieramici, MD, has the following relevant financial relationships:
    Advisor or consultant for: Adverum Biotechnologies; Genentech; Gemini Pharmaceuticals Inc.; Novartis; Regeneron; REGENXBIO, Inc.
    Grants for clinical research from: Appelis Pharmaceuticals; Adverum Biotechnologies; Gemini Pharmaceuticals Inc.; Genentech; Ionis Pharmaceuticals; Kodiac Sciences; NGM Biopharmaceuticals, Inc.; Novartis; Regeneron; REGENXBIO, Inc.; Roche; Stealth BioTherapeutics

  • Charles C. Wykoff, MD, PhD

    Physician and Director of Research
    Retina Consultants of Houston
    Houston Methodist Hospital
    Blanton Eye Institute
    Houston, Texas

    Disclosures

    Disclosure: Charles C. Wykoff, MD, PhD, has the following relevant financial relationships:
    Advisor or consultant for: Adverum Biotechnologies; Aerie Pharmaceuticals; Allergan; Allgenesis; Alimera Sciences; Amgen; Apellis Pharmaceuticals; Arrowhead Pharmaceuticals; AsclepiX Therapeutics; Bausch + Lomb; Bayer; Bionoc Vision Technologies; Boehringer Ingelheim; Chengdu Kanghong Pharmaceutical Group Co., Ltd; Clearside Biomedical; Eyepoint Pharmaceuticals; Genentech; Gyroscope Therapeutics; Ionis Pharmaceuticals; IRenix Medical; Iveric Bio; Janssen; Kato Pharmaceuticals; Kodiak Sciences; Long Bridge Medical, Inc.; Lowy Medical Research Institute; NGM Biopharmaceuticals, Inc.; Novartis; OccuRx; Ocular Therapeutix; ONL Therapeutics; Opthea Ltd; Oxurion; Palatin Technologies, Inc.; PolyPhotonix; RecensMedical; Regeneron; REGENXBIO; Roche; SamChunDang Pharm; Surrozen; Taiwan Liposome Company; Takeda; Verana Health; Vitranu; Xbrane Biopharma
    Grants for clinical research from: Adverum Biotechnologies; Aerie Pharmaceuticals; Aldeyra Therapeutics; Alimera Sciences; Allergan; Amgen; Annexon Biosciences; Apellis Pharmaceuticals; AsclepiX Therapeutics; Bayer; Boehringer Ingelheim; Chengdu Kanghong Pharmaceutical Group Co., Ltd; Clearside Biomedical; Gemini Pharmaceuticals, Inc.; Genentech; Graybug Vision; Gyroscope Therapeutics; Ionis Pharmaceuticals; IRenix Medical; Iveric Bio; Kodiak Sciences; Lowy Medical Research Institute; Nanoscope Therapeutics; Neurotech Pharmaceuticals; NGM Biopharmaceuticals, Inc.; Novartis; Opthea Ltd; Oxurion; RecensMedical, Inc.; Regeneron; REGENXBIO; Roche; SamChunDang Pharm; Taiwan Liposome Company; XBrane Biopharma
    Stocks, stock options, or bonds from: ONL Therapeutics; PolyPhotonix; RecensMedical; Visgenx, Inc.

Editors

  • Pakinam Aboulsaoud, PharmD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Pakinam Aboulsaoud, PharmD, has disclosed no relevant financial relationships.

  • Yoji Yamaguchi, MA, ELS

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Yoji Yamaguchi, MA, ELS, has disclosed no relevant financial relationships.

CME Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Postgraduate Institute for Medicine and Medscape.

Medscape

Interprofessional Continuing Education

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Medscape, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    For Optometrists

    Postgraduate Institute for Medicine

    Interprofessional Continuing Education

    In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Medscape. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.

    Credit Statement: This course is COPE approved for 0.5 hours of CE credit. Activity #122779 and Course ID 75193-PS. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.

    Contact this provider www.pimed.com

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

Physicians

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

Optometrists

1.     Go to www.cmeuniversity.com

2.     Login or Create a New Account (will take less than 1 minute)

  •       a.     If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
  •       b.     After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page

3.     Type in 16827 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter

4.     Click on the activity title when it appears

5.     Choose the type of credit you desire

6.     Complete the online assessment 

7.     Receive an immediate CME/CE Certificate to download and/or print for your files

CME

New Frontiers in Sustained Delivery: New Data and Surgical Advances for Age-Related Macular Degeneration and Diabetic Eye Disease

Authors: Carl D. Regillo, MD; Dante J. Pieramici, MD; Charles C. Wykoff, MD, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 10/28/2021

Valid for credit through: 10/28/2022, 11:59 PM EST

processing....

  • Print